Khiron Life Sciences Corp V.KHRN.H

RE:RE:RE:40 cents floor resistance broken

[Benedictus]

You can believe I'm an uneducated idiot all you want ORT. It doesn't change the fact that management lost a ton of credibility by doing this pp with so much cash on hand. Worse yet, according to the lataest update from Ted Ohashi, this pp was done merely because the "opportunity presented itself". A potentially 50% dilution done with plenty of cash on hand and the share price near all time lows is anathema to the shareholders best interest. If the company truly will be cash flow neutral by Q1 21, then this is an even bigger slap in the face as management would have been in a  far better position to do a raise then and with a higher share price. Cash neutral assumes a significant revenue ramp in the coming 2 quarters.  And based on all information released to date, the numbers do not add up imo. 

Since you are so educated please school me on what valuation metrics you are using to get your .60 price target. Oh and please remember to use the new diluted share count in your calculations. I'm quite curious how exactly you can justify a 100M+ market cap based on actual revenues and margins. I've run the numbers on the Columbian script build and I've also noted the complete lack of transparency around the UK script issuance leading me to question my very generous initial revenue assumptions in that market. 

I have been bullish on khiron until this pp. Now I am neutral with a bearish slant and I will watch from the sidelines and see if management can prove their multi country model actually works.